The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
News the HIV world has been waiting for – long-acting injectable cabotegravir (CAB-LA) is a potentially game-changing tool to prevent HIV in women.
The 23rd International AIDS Conference (AIDS 2020 Virtual) kicked-off with a clear message from UNAIDS to accelerate efforts to end AIDS and not be derailed by COVID-19.
The 2020 goal of reaching 120 million additional girls and young women with modern contraceptives is likely to be missed, despite millions of new users.
The President’s Emergency Plan for AIDS Relief (PEPFAR) is to accelerate efforts in just 13 countries under its news strategy. But critics say this narrowed focus could lead to a resurgence of the HIV epidemic.
Savings would be ‘small and transient’ – raising significant ethical and efficacy concerns about the benefit of US budget cuts for HIV programming abroad.
Ending paediatric AIDS is now within our reach thanks to the mass scale-up of prevention of mother-to-child transmission (PMTCT) services. However, the treatment needs for children already living with HIV must to be urgently addressed.
World Health Organization (WHO) guidelines call for all people newly diagnosed to start treatment straight away – but worrying numbers of people in high-burden countries still test and present late to care.
Treatment access gains are to be applauded – but we will get nowhere if we don’t prevent more new infections and reach out to key affected populations.
New HIV infections among adolescent girls and young women fell by only 6% between 2010 and 2015. This puts the HIV response severely off-track to reach the UNAIDS 2020 Fast-Track Targets.
2015 has been a momentous year for the HIV response and global development. Bold commitments have been made to accelerate efforts towards the common goal of ending AIDS as a global public health threat by 2030.
